Franz-Werner Dippel MSc
is project manager for health economics/care research in the area of metabolism (diabetes) in the medical department, Sanofi Aventis Deutschland GmbH. Studied biology at the Johann Wolfgang von Goethe University, Frankfurt. Has worked in various positions in the pharmaceutical industry since 1984.
Articles
- Treatment costs for diabetes mellitus: Comparison of three basal insulin-based therapeutic approaches
Issue 05/2011
- Insulin glargine and exenatide in type 2 diabetes: A cost comparison in combination with oral antidiabetics
Issue 05/2010
- The risks of health services research
Issue 02/2013
- The risks of health services research
Issue 02/2013
- Incidence of cardiovascular events in insulin-treated type 2 diabetes patients under real-world care conditions
Issue 01/2012
- Insulin glargine: a cost-effective alternative compared to NPH insulin
MVF 06/09
- Comparison of treatment costs for insulin-dependent type 2 diabetics in everyday care
MVF 02/09